logo
Malaysia on track to become healthcare hub

Malaysia on track to become healthcare hub

The Star4 days ago
PETALING JAYA: Malaysia is poised to be a major healthcare hub due to quality care, advancing technologies and growth in the sector, says MBSB Research.
However, the research house said it believes challenges persist due to the country's ageing population, increasing prevalence of non-communicable diseases and communicable diseases, as well as financing pressures.
'The challenges are no longer just about basic access, which has largely been achieved in Peninsular Malaysia, but about quality, efficiency, equity and sustainability in the face of rising costs and demand.
'Malaysia is not adhering rigidly to one ideological model – fully public or fully private. Instead, it's embracing a pragmatic, dual-tier system with increasing public-private partnerships,' the research house said.
It pointed out that the Malaysian healthcare industry is in a critical phase of transformation, where the success of the journey will depend on the ability to effectively implement strategic changes.
MBSB Research added that the country has a strong foundation in the healthcare sector as well as a clear understanding of its complex challenges and an ambitious roadmap for reform.
The research house believes the country will need to sustain the political will to navigate the inherent difficulties of comprehensive reforms, ultimately aiming for a truly equitable, high-quality and sustainable healthcare system for all.
It said it believes that the government's continued heavy subsidisation of public healthcare and the active pursuit of universal health coverage through various initiatives demonstrate a fundamental commitment to ensuring that healthcare remains a right for all citizens.
This was evident by the Budget 2025's allocation of RM45.3bil for the local healthcare sector. 'The willingness to address high out-of-pocket payments also directly signifies a focus on financial-risk protection for its citizens,' it said.
It added that the Health Ministry's emphasis on digitalisation, data analytics and value-based healthcare also indicates a forward-looking approach.
MBSB Research maintained its 'positive' stance on the sector due to its resilient support from the government, the drive from ongoing trends and the leverage of contributing to local and regional economies.
It expects the Malaysian healthcare sector's overall revenue to grow at a five-year compound annual growth rate of between 6% and 8% up to 2030.
Its top pick for the sector is KPJ Healthcare Bhd , as it is well-positioned to capitalise on the sector's positive outlook due to its established market presence, strategic growth initiatives and improving financial performance.
'With its large network of private hospitals (30 hospitals and four ambulatory care centres), the group has strong brand recognition across the country while serving the growing domestic demand for quality and affordable private healthcare services,' the research house said.
KPJ also has the advantage of improving its operational efficiencies through its 'KPJ Health System' framework, while heavily investing in digital capabilities with about RM400mil allocated for digitalisation and advanced medical technology.
'Overall, KPJ's robust growth strategy, strong financial performance and leading market position in a structurally growing sector make it an attractive proposition in the Malaysian healthcare landscape,' MBSB Research added.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Madani BFHI tour promotes breastfeeding in Malaysia
Madani BFHI tour promotes breastfeeding in Malaysia

The Sun

time6 hours ago

  • The Sun

Madani BFHI tour promotes breastfeeding in Malaysia

SEREMBAN: The Health Ministry has introduced the Madani Private Hospital Baby-Friendly Hospital Initiative (BFHI) 2025 to encourage breastfeeding and lower the prevalence of diet-related non-communicable diseases (NCDs). Deputy Health Minister Datuk Lukanisman Awang emphasized the importance of public-private collaboration in supporting nursing mothers. 'The core objectives of this tour align with the National Nutrition Policy, aiming to expand BFHI promotion, engage more private hospitals, and strengthen community support for nursing mothers,' he said during the launch. Currently, 31 out of 180 private hospitals have received BFHI accreditation, with KPJ Healthcare leading as the largest accredited consortium. The initiative includes hospital visits across Malaysia, such as Sri Kota Specialist Medical Centre and KPJ Klang Specialist Hospital in August, followed by others in September. Lukanisman highlighted that exclusive breastfeeding provides a natural, pollutant-free diet, promoting sustainable public health and reducing reliance on commercial baby food. 'Fifteen hospitals are in the final training stage for accreditation, while 65 are undergoing initial training,' he added. BFHI, a global effort by WHO and UNICEF since 1991, focuses on protecting and promoting breastfeeding. - Bernamapix

News@9: Today's top headlines - July 25, 2025 [WATCH]
News@9: Today's top headlines - July 25, 2025 [WATCH]

New Straits Times

time6 hours ago

  • New Straits Times

News@9: Today's top headlines - July 25, 2025 [WATCH]

Here are tonight's top stories: Prime Minister Datuk Seri Anwar Ibrahim has told the Health Ministry to speed up the hiring of 4,325 doctors, including contract roles. Putrajaya is calling on Thailand and Cambodia to exercise restraint and de-escalate tensions after a clash along their shared border. Sixteen roads in downtown Kuala Lumpur will be closed for the Turun Anwar rally. Police said motorists should plan alternate routes. The Malaysian duo are set to climb to world No. 2 after reaching the China Open semi-finals in Changzhou on Friday. That's all for News@9.

Healthy outlook seen for healthcare industry
Healthy outlook seen for healthcare industry

The Star

time7 hours ago

  • The Star

Healthy outlook seen for healthcare industry

PETALING JAYA: Analysts are positive on the Malaysian healthcare sector, driven by its resilient long-term structural growth drivers, positioning it as a compelling defensive play amid ongoing macroeconomic uncertainty. Hong Leong Investment Bank (HLIB) Research has maintained its 'overweight' stance on the healthcare sector for 2025, with a clear preference for the hospital segment. 'Also, we see further upside from a domestic-focused thematic play from an initial public offering-led re-rating, driven by the anticipated listings of Sunway Healthcare Group, expected in late-2025 or early-2026,' it said. The research house has kept its 'buy' rating on IHH Healthcare Bhd , with a higher sum-of-parts-derived target price of RM9.15 from RM9.06. 'The marginal upward revision reflects the latest market capitalisations of its India-listed Fortis Healthcare and Singapore-listed Parkway Life Real Estate Investment Trust, which have seen slight valuation uplifts. HLIB Research has also upgraded KPJ Healthcare Bhd to a 'buy' from 'hold' with an unchanged target price of RM2.96, driven by the recent share price weakness that has improved its risk-reward profile. It has, however, maintained its 'hold' rating on UMediC Group Bhd , but lowered its target price to 31.5 sen from 40 sen. This is based on a reduced target price over an earnings multiple of 15 times applied to its 2026 earnings per share estimate of 2.1 sen. 'The downward adjustment in valuation multiple reflects waning investor interest, following three consecutive quarters of earnings underperformance, and a muted outlook in the fourth quarter of 2025. 'Until earnings visibility improves, we expect sentiment to remain subdued,' it explained. Meanwhile, MBSB Research, which has maintained a positive outlook on the healthcare sector, said the pharmaceutical market is fundamentally driven by robust demographic trends, which naturally increases the demand for healthcare services and medicines. 'The growing prevalence of non-communicable diseases such as cancer, diabetes and cardiovascular conditions, which require long-term medication and fuel sustained pharmaceutical consumption, is expected to continue to support all levels of the healthcare sector. 'Hence, we believe the growth in the pharmaceutical market will continue to grow in tandem with the expansion of investments in healthcare infrastructure (assets, accessibility and affordability),' it added. It pointed out that while direct pharmaceutical exports from Malaysia to the United States might face immediate headwinds from tariffs, the broader impact on the healthcare sub-sector could come from indirect effects on global pharmaceutical supply chains and procurement costs. 'This would affect the affordability and availability of medicines within Malaysia for all citizens and healthcare providers. 'The Malaysian government and industry players are already responding by prioritising supply chain diversification and exploring domestic production enhancements to mitigate these risks,' the research house said. It believes a multi-pronged approach involving government action, industry adaptation and consumer awareness will be crucial. HLIB Research, meanwhile, viewed the government's recent decision to implement the diagnosis-related group payment system, specifically for the upcoming 'basic health insurance and takaful products'. It said the targeted approach helps to improve accessibility for those priced out of existing insurance/takaful plans, while preserving the commercial viability of the private healthcare sector.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store